InsidersTradesSigma
Track the Insys Therapeutics, Inc. share price and the full directors' dealings record of the company, a listed equity based in United States. Shares are listed on the US market, under the oversight of SEC (Form 4). Market capitalisation: €2.2bn. The latest transaction was filed on 9 February 2016 (Levée d'options). Among the most active insiders: MEYER STEVEN J. All data is free.
Analysts rate Insys Therapeutics, Inc. Strong Buy (bullish), based on 12 analysts. Average price target: US$59.30.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
Insys Therapeutics, Inc. is a pharmaceutical company focused on developing treatments, particularly for pain management. It is listed on the NASDAQ under the ticker symbol INSY.